Table.
Patient No./Sex/Age, y/Eye | Agent | Grade | Key Findings | Time Between Burn and AMP | Day(s)of Change or Removal of ProKeraa | Reepithelialization Time, d | Visual Acuity, Before (After) | Clinical Outcome | Follow-up, mo |
---|---|---|---|---|---|---|---|---|---|
1/F/53/L | Bleach | I | Co: Clear, 70% ED Li: 120° ED, no ischemia Cj: 30% ED, severe inflammation |
16 h | 3 | Co: 5 Cj: 5 |
20/50 (20/20) | Co: Clear Li: No LSCD Cj: No symblepharon |
28 |
2/M/32/R | Lime | II | Co: mild haze, 60% ED Li: 150° ED, 75° ischemia Cj: 30% ED, moderate inflammation |
2 d | 6 | Co: 6 Cj: 6 |
20/30 (20/20) | Co: Clear Li: No LSCD Cj: No symblepharon |
9 |
3/M/38/L | Caustic soda | II | Co: 100% ED, moderate haze Li: 360° ED, no ischemia Cj: 50% ED, moderate inflammation |
2 d | 6, 11, 17, 21 | Co: 25 Cj: 6 |
20/400 (20/200)b | Co: Faint central haziness, stationary inferior superficial NV Li: No LSCD Cj: No symblepharon |
7 |
4/F/27/R | Floor cleaner | II | Co: 100% ED, mild haze Li: 360° ED, 75° ischemia Cj: 60% ED, moderate inflammation |
8 d | 5, 10, 15 | Co: 17 Cj: 17 |
20/200 (20/25) | Co: Faint central haziness, stationary peripheral NV Li: No LSCD Cj: Localized early inflammation and granulation outside ProKera resolved by steroid injection, no symblepharon |
29 |
5/M/3/R | Cement | III | Co: 75% ED, severe haze Li: 140° ED, 150° ischemia Cj: 30% ED, moderate inflammation, early symblepharon (x2) |
4 d | 7, 14 | Co: 15 Cj: 7 |
CSM (CSM) | Co: Faint inferior haziness, stationary inferior superficial NV Li: No LSCD Cj: No symblepharon |
11 |
Abbreviations: AMP, amniotic membrane patch; Cj, conjunctiva; Co, cornea; CSM, central steady maintain; ED, epithelial defect; F, female; L, left; Li, limbus; LSCD, limbal stem cell deficiency; M, male; NV, neovascularization; R, right.
Bio-Tissue, Inc, Miami, Florida.
Amblyopic eye.